Report Events

[Registration Open] (Webinar) Special International Forum: The Importance of Vaccines and Japan’s Role in Global Health (October 22, 2021)

[Registration Open] (Webinar) Special International Forum: The Importance of Vaccines and Japan’s Role in Global Health (October 22, 2021)

Health and Global Policy Institute (HGPI) will convene online Special International Forum: “The Importance of Vaccines and Japan’s Role in Global Health.” 

The importance of vaccines in the context of global health has started to take up more space in the vaccine policy debate than ever before. As the impact of COVID-19 is felt in developing, as well as developed countries, a global, collaborative framework (ACT-A: Access to COVID-19 Tools Accelerator) to accelerate access to tools related to COVID-19 has been launched. The ACT-A addresses diagnosis, treatment, vaccines, health systems, access, and distribution, with a focus on the procurement and distribution of vaccines through the COVAX Facility, a multilateral framework for the procurement of safe and approved vaccines. Furthermore, international contributions are being made through bilateral vaccine donations. Japan has engaged in various international cooperation initiatives through its Strategy on Global Health Diplomacy, approved by the Cabinet in 2013, and the Basic Design for Peace and Health (Global Health Cooperation), created in 2015. In addition, the ASEAN Centre for Public Health Emergencies and Emerging Diseases will be established with the understanding that preparation for and response to emerging diseases is connected to a stable socio-economic environment in neighbouring countries and that responding to infectious diseases is essential and mutually beneficial. In July 2020, about 5.5 billion yen had been contributed to the center.

At the same time, the international supply of COVID-19 vaccines has been unevenly distributed, with middle- and high-income countries receiving more vaccines and low-income countries receiving far fewer. Recently, there have been calls around the world for vaccines to be classified as “Global Public Goods.”

In the past, the Japanese government has led discussions on international frameworks for global health at the G7 Ise-Shima Summit and the G20 Osaka Summit. However, there have been few opportunities to draw public attention to the government’s efforts. It is essential that we expand the conversation to promote public and stakeholder interest and understanding of international contributions and diplomatic issues related to COVID-19.

With that in mind, the Health and Global Policy Institute will host a Special International Forum focusing on Japan’s global provision of COVID-19 vaccines, the COVAX Facility’s current status and prospects, and Japan’s future role in health diplomacy. Experts from industry, government, academia, and the private sector in Japan and abroad will engage in discussions on the significance of medicines, including vaccines, to global health and the role expected of Japan moving forward. The discussions will form the basis of policy recommendations to be released at a later time.



■Date: Friday, October 22, 2021, 15:30-18:00 JST

■Format: Zoom Webinar

■Participation Fee: Free

■Language: English and Japanese (simultaneous interpretation available)

■Host: Health and Global Policy Institute

■Co-host: The British Embassy Japan


■Program:(Titles omitted)

15:30-15:35   Opening Address (1) 
 Kiyoshi Kurokawa (Chairman, Health and Global Policy Institute)

15:35-15:40   Opening Address (2) 
 Julia Longbottom (British Ambassador to Japan)

15:40-15:45   Event Overview
 Ryoji Noritake (CEO & Board Member, Health and Global Policy Institute)

15:45-16:00   Keynote Speech (1)   Lessons Learned from UK’s Vaccine Rollout and Global Health Strategy
 Saul Walker (Deputy Head of COVID-19 Vaccines, Therapeutics and Diagnostics Strategy, Foreign Commonwealth and Development Office(FCDO), UK)

16:00-16:15   Keynote Speech (2)   Japan’s International Collaboration Efforts in the COVID-19 Era
 Satoshi Ezoe (Director, Global Health Policy Division, Ministry of Foreign Affairs, Japan)

16:20-17:50   Panel Discussion
 Theme 1: The Implications of Global Vaccine Provision
 Theme 2: The Future of Global Health

 Mihoko Kashiwakura (Head of East Asia Relations, Bill & Melinda Gates Foundation)
 Keizo Takemi (Member of the House of Councilors; WHO Goodwill Ambassador for UHC)
 Atsushi Sunami (President, The Sasakawa Peace Foundation)
 Kayo Takuma (Professor, Tokyo Metropolitan University)
 Suwit Wibulpolprasert (Senior Advisor, Thai Ministry of Health)

 Joji Sugawara (Manager, Health and Global Policy Institute)

17:50-18:00   Closing Remarks
 Noriko Furuya (Member of the House of Representatives; Acting Chairperson, Association for the Promotion of Improved Public Health, Parliamentary Group for Vaccines and Prevention)

*Please find out the brochure at the bottom of this website for more information.

Back to Events